Warren Buffett's Berkshire Compounded at 19.9% a Year Over 60 Years as CEO, Nearly Double the S&P 500's Return. Can Investors Still Expect That Playbook Today?

Berkshire Hathaway has underperformed the S&P 500 over the past three-, five-, and 10-year periods, and Warren Buffett said in his 2023 shareholder letter that there was “no possibility of eye-popping performance.” New CEO Greg Abel has largely maintained Berkshire’s model and completed the $6.8 billion acquisition of homebuilder Taylor Morrison in July. The article argues Berkshire can still deliver steady long-term growth, but its much larger scale makes a repeat of its historical 5,500,000% stock gain unlikely.

Analysis

The key issue is capital-deployment capacity, not whether the leadership handoff preserves the old playbook. At Berkshire’s scale, even disciplined investing may not translate into market-beating per-share growth: fewer opportunities can absorb meaningful capital, while a large cash balance can support downside resilience but dilute returns if deployment is slow. That argues against valuing BRK.A as a repeat of its historical compounding record; it does not, by itself, make the shares a short.

The claimed Taylor Morrison acquisition is a material verification item, not a sound trading input until confirmed independently. If true, it would add direct exposure to housing demand and mortgage-rate sensitivity, and could put Berkshire’s capital to work in a cyclical business; if false, any TMHC positioning based on this report risks trading a fabricated link. The Alphabet position is not enough on its own to imply a change in Berkshire’s investment process.

Near term, the succession narrative may matter more than operating fundamentals, but a durable re-rating requires evidence: per-share book-value progression, operating earnings, and returns on new capital under Abel. Over 6–18 months, persistent cash accumulation alongside weak incremental returns would reinforce the lower-growth view. Conversely, attractive deployment and stable insurance economics could support Berkshire as a defensive compounder. The contrarian point: historical index underperformance is not proof of a broken franchise, but defensive quality alone is not a catalyst for outperformance.

Key Decisions for Investors

• Do not trade the reported Taylor Morrison transaction until it is corroborated by Berkshire and Taylor Morrison filings or company statements; do not infer that TMHC is a Berkshire subsidiary from this article alone.
• No outright BRK.A short on the historical underperformance narrative. Consider a relative-value long versus SPY only after checking current valuation and balance-sheet data, with the thesis centered on defensive resilience rather than a return to past excess returns.
• For the next 1–3 months, monitor Berkshire’s disclosures for capital deployment, cash levels, and per-share operating earnings. Persistent cash growth without attractive investment returns would weaken the case for a relative long; credible high-return deployment would strengthen it.
• Treat housing exposure as conditional: if the acquisition is verified, assess mortgage rates, homebuilder orders, and Berkshire’s disclosed purchase terms before expressing a view on TMHC or the housing cycle.